NCI's Reorganization, Director Scrutinized By Cancer BoardBy Myrna E. Watanabe
Little official business was concluded at a two-day meeting of the National Cancer Advisory Board (NCAB) November 28-29. Rather, the proceedings were dominated by a lavish presentation of the wide-ranging reorganization of the National Cancer Institute (NCI) and its mercurial director, Richard D. Klausner, who orchestrated the restructuring.
Klausner announced, for the first time, the "profound administrative changes" that he began to implement at NCI after he took over this position in August. He proclaimed that as of October 1, the reorganization of NCI was completed.
CHANGES AFOOT: Director Richard Klausner presented NCI's "profound restructuring" to the advisory board. "Completed" may be something of an overstatement, however. As a fax from Klausner's office to The Scientist outlining the NCI organization clearly indicates-with its crossing out of branches and penciling in...